4//SEC Filing
Brockstedt Dirk G. 4
Accession 0001593968-22-000858
CIK 0001673772other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 7:05 PM ET
Size
10.4 KB
Accession
0001593968-22-000858
Insider Transaction Report
Form 4
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2022-04-11$23.05/sh−2,647$61,013→ 19,812 total - Exercise/Conversion
Option (right to buy)
2022-04-11−1,290→ 2,113 totalExercise: $6.18Exp: 2028-03-27→ Common Stock (1,290 underlying) - Exercise/Conversion
Common Stock
2022-04-11$6.18/sh+2,647$16,358→ 22,459 total - Exercise/Conversion
Option (right to buy)
2022-04-11−1,357→ 15,690 totalExercise: $6.18Exp: 2028-03-27→ Common Stock (1,357 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001635616
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 7:05 PM ET
- Size
- 10.4 KB